Monterey Bio Acquisition Corporation

MTRYNASDAQFinancial Services

$11.14

$-0.03(-0.27%)

Market Cap$48302260

P/E Ratio—

52W High$12.0

52W Low$10.21

Avg Volume3K

Open$11.16

Beta0.00

Overview

Monterey Bio Acquisition Corporation (MTRY) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

MTRY · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2023Report Date: Jun 30, 2023

EPS Actual

-$0.03

Revenue

—

Fiscal Period

Q2 FY2023

FY ends December

Report Date

Jun 30, 2023

After Market Close

MTRY reports quarterly as a NASDAQ-listed Shell Companies company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2023	Jun 30, 2023	—	-$0.03	—	—	—	—
— Q1 FY2023	Mar 31, 2023	—	-$0.03	—	—	—	—
— Q4 FY2022	Dec 31, 2022	—	-$0.11	—	—	—	—

Q2 FY2023

Jun 30, 2023

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2023

Mar 31, 2023

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2022

Dec 31, 2022

EPS Actual

-$0.11

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High
Q3 FY2024	$1.54	$1.54	$1.54
Q2 FY2024	$1.34	$1.34	$1.34
Q1 FY2024	$1.58	$1.58	$1.58
Q4 FY2023	$2.09	$2.09	$2.09
Q3 FY2023	$1.39	$1.39	$1.39
Q2 FY2023	$1.19	$1.19	$1.19

Revenue Estimates

Period	Low	Consensus	High
Q3 FY2024	$0.0B	$0.0B	$0.0B
Q2 FY2024	$0.0B	$0.0B	$0.0B
Q1 FY2024	$0.0B	$0.0B	$0.0B
Q4 FY2023	$0.0B	$0.0B	$0.0B
Q3 FY2023	$0.0B	$0.0B	$0.0B
Q2 FY2023	$0.0B	$0.0B	$0.0B

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2023	Jun 30, 2023	—	$10.92	$10.92	+0.00%
— Q1 FY2023	Mar 31, 2023	—	$10.68	$10.68	+0.00%
— Q4 FY2022	Dec 31, 2022	—	$10.50	$10.45	-0.48%

Q2 FY2023+0.00%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$10.92

Price After

$10.92

Q1 FY2023+0.00%

Report Date

Mar 31, 2023

EPS Beat/Miss

—

Price Before

$10.68

Price After

$10.68

Q4 FY2022-0.48%

Report Date

Dec 31, 2022

EPS Beat/Miss

—

Price Before

$10.50

Price After

$10.45

Beat Rate0 / 3 quarters

Largest Move-0.48% (Q4 FY2022)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Monterey Bio Acquisition Corporation (MTRY) most recently reported earnings on June 30, 2023 for Q2 FY2023, posting EPS of $-0.03 (in line with the analyst consensus of —). The next MTRY earnings date is expected around September 1, 2026.

Each quarter, investors track MTRY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MTRY revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

MTRY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

MTRY earnings · 4 questions

Monterey Bio Acquisition Corporation's next earnings report is expected around September 1, 2026. MTRY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MTRY historically reports after market close (AMC).

MTRY earnings datewhen is MTRY earningsMTRY next earnings datewhen does MTRY report earningsMTRY earnings calendar

▸ Source: FMP · Monterey Bio Acquisition Corporation SEC filings · US GAAP · Monterey Bio Acquisition Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026